Analisis Keuangan Saham 1RT - Nuformix plc (DB) Stock

Gambaran Umum

Nuformix plc is a pharmaceutical development company based in the United Kingdom, primarily engaged in leveraging its proprietary cocrystal technology to repurpose small-molecule therapeutics. This technology offers novel versions of known drugs, which aim to enhance their performance characteristics, including efficacy, safety, and patient experience. The company's portfolio predominantly focuses on the high-value areas of fibrosis and oncology, alongside other therapeutic domains. Key projects include NXP002 for the treatment of fibrosis and NXP004, which involves developing new forms of existing molecules with known clinical activity. By re-engineering existing drugs, Nuformix plc aims to reduce development risk, cost, and time to market compared to developing entirely new drugs.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai operating income untuk Nuformix plc per 2025 Mar 31 adalah -0.64 MM.
Nilai net income untuk Nuformix plc per 2025 Mar 31 adalah -3.78 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-03-31		-0.64	-3.78
2024-12-31		-0.57	-3.71
2024-09-30		-0.51	-3.64
2024-03-31		-0.52	-0.48
2023-09-30		-0.62	-0.57
2023-03-31		-0.76	-0.76
2022-12-31	0.00	-1.00	-0.92
2022-09-30	0.00	-1.24	-1.08
2022-06-30	0.03	-1.26	-1.10
2022-03-31	0.05	-1.27	-1.11
2021-12-31	0.05	-1.31	-1.17
2021-09-30	0.05	-1.35	-1.23
2021-06-30	0.12	-1.36	-1.24
2021-03-31	0.20	-1.37	-1.25
2020-12-31	0.20	-1.32	-1.18
2020-09-30	0.20	-1.26	-1.10
2020-06-30
2020-03-31

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-03-31
2024-12-31
2024-09-30	-0.00
2024-03-31
2023-09-30	-0.00	-0.00
2023-03-31	-0.00
2022-12-31	-0.00	-0.00
2022-09-30	-0.00	-0.00
2022-06-30	-0.00	-0.00
2022-03-31	-0.00
2021-12-31	-0.00	-0.00
2021-09-30	-0.00	-0.00
2021-06-30	-0.00	-0.00
2021-03-31	-0.00
2020-12-31	-0.00	-0.00
2020-09-30	-0.00	-0.00
2020-06-30	-0.00	-0.00
2020-03-31	-0.00

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk Nuformix plc per 2025 Mar 31 adalah -0.55 MM.
Nilai kas dari aktivitas pendanaan untuk Nuformix plc per 2025 Mar 31 adalah 0.47 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-03-31	-0.55		0.47
2024-12-31	-0.44		0.31
2024-09-30	-0.33		0.15
2024-03-31	-0.47	0.03	0.38
2023-09-30	-0.40	0.03	0.19
2023-03-31	-0.43		0.23
2022-12-31	-0.76		0.32
2022-09-30	-1.09		0.40
2022-06-30	-1.22		0.27
2022-03-31	-1.35		0.14
2021-12-31	-1.23	0.02	1.03
2021-09-30	-1.12	0.04	1.93
2021-06-30	-0.98	0.04	1.93
2021-03-31	-0.85	0.04	1.93
2020-12-31	-0.90	0.01	1.50
2020-09-30	-0.96	-0.02	1.06
2020-06-30
2020-03-31

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-03-31
2024-12-31
2024-09-30
2024-03-31
2023-09-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-03-31
2024-12-31	0.00	-1.32
2024-09-30	0.00	-0.76
2024-03-31
2023-09-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Efektivitas Manajemen

roa untuk Nuformix plc pada 2025 Mar 31 adalah -0.82.
roe untuk Nuformix plc pada 2025 Mar 31 adalah -0.90.
roic untuk Nuformix plc pada 2025 Mar 31 adalah -5.09.
croic untuk Nuformix plc pada 2025 Mar 31 adalah -0.25.
ocroic untuk Nuformix plc pada 2025 Mar 31 adalah -0.46.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-03-31	-0.82	-0.90	-5.09	-0.25	-0.46
2024-12-31	0.00	0.00
2024-09-30	-0.82	-0.87
2024-03-31	-0.13	-0.14	-0.14	-0.04	-0.09
2023-09-30	-0.16	-0.17	-0.18	-0.05	-0.10
2023-03-31	-0.22	-0.16	-0.18	-0.05	-0.10
2022-12-31	-0.20	-0.21	-0.24	-0.15	-0.24
2022-09-30	-0.20	-0.21	-0.24	-0.15	-0.24
2022-06-30	0.00	0.00	0.00
2022-03-31	-0.20	-0.20	-0.23	-0.25	-0.28
2021-12-31	-0.20	-0.21	-0.25	-0.04	-0.21
2021-09-30	-0.27	-0.29	-0.23	0.16	-0.15
2021-06-30	-0.27	-0.29	-0.24	0.19	-0.19
2021-03-31	-0.24	-0.26	-0.22	0.20	-0.15
2020-12-31	-0.23	-0.25	-0.21	0.11	-0.16
2020-09-30	-0.24	-0.28	-0.25	0.02	-0.22
2020-06-30	-0.20	-0.23	-0.21	0.07	-0.19
2020-03-31	-0.16	-0.20	-0.16	0.11	-0.15

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-03-31
2024-12-31
2024-09-30
2024-03-31
2023-09-30
2023-03-31
2022-12-31
2022-09-30	0.97
2022-06-30		0.00	-50.30
2022-03-31	2.03	-22.18	-25.41
2021-12-31	2.03	-23.37	-26.18
2021-09-30	0.68	-24.56	-26.96
2021-06-30	0.96	-10.11	-11.08
2021-03-31	0.68	-6.41	-7.02
2020-12-31	-0.04	-6.02	-6.59
2020-09-30	-0.76	-5.62	-6.45
2020-06-30	0.07	-2.54	-2.98
2020-03-31	0.38	-1.41	-1.71